lithium succinate 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definitionDrug idCAS RN
4590 16090-09-8

Description:

MoleculeDescription

Synonyms:

  • lithium succinate
  • efadermin
lithium important for treatment of genital herpes
  • Molecular weight: 129.95
  • Formula: C4H4Li2O4
  • CLOGP:
  • LIPINSKI: None
  • HAC: None
  • HDO: None
  • TPSA: 80.26
  • ALOGS:
  • ROTB: None

Drug dosage:

None

ADMET properties:

None

Approvals:

None

FDA Adverse Event Reporting System (Female)

None

FDA Adverse Event Reporting System (Male)

None

FDA Adverse Event Reporting System (Geriatric)

None

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

SourceCodeDescription
ATC D11AX04 DERMATOLOGICALS
OTHER DERMATOLOGICAL PREPARATIONS
OTHER DERMATOLOGICAL PREPARATIONS
Other dermatologicals

Drug Use (View source of the data)

None




🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

None

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

None

External reference:

IDSource
CHEMBL3707288 ChEMBL_ID
C038377 MESH_SUPPLEMENTAL_RECORD_UI
DB14508 DRUGBANK_ID
10197702 PUBCHEM_CID
28817 RXNORM
004131 NDDF
395771006 SNOMEDCT_US
421421006 SNOMEDCT_US
C0065093 UMLSCUI

Pharmaceutical products:

None